Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133)Makoto Nishio, Tomohisa Kawakami, Shinji Atagi et al.|Clinical Lung Cancer|2019Cited by 48